Seres Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $28.00K, a 84.78% decline year-over-year.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $46.00K, a 65.67% decline year-over-year.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $184.00K, a 47.88% decline year-over-year.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $134.00K, a 85.47% decline year-over-year.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $230.00K, a 52.77% decline from fiscal 2024.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $487.00K, a 77.36% decline from fiscal 2023.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $2.15M, a 21.59% increase from fiscal 2022.
- Seres Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.77M, a 113.91% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $28.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $230.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $46.00K 10-Q · filed 2025-11-05 | |
| 2025-03-31 | $184.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $487.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $134.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $353.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $2.15M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $922.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $1.23M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $1.77M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $877.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $892.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $827.00K 10-K · filed 2024-03-05 | |
| 2021-09-30 | $435.00K 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $392.00K 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $462.00K 10-K · filed 2023-03-07 | |
| 2020-09-30 | $213.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $249.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $296.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $89.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $207.00K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $257.00K 10-K · filed 2021-03-02 | |
| 2018-09-30 | $257.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |